SD Biosensor, Inc (KRX:137310)

SD Biosensor Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	128,973	177,424	482,383	1,872,944	881,593	243,216
Short-Term Investments	288,945	280,315	75,334	48,238	323,595	100,683
Trading Asset Securities	14,330	10,011	-	148,789	690,310	95,014
Cash & Short-Term Investments	432,248	467,750	557,717	2,069,971	1,895,499	438,913
Cash Growth	0.34%	-16.13%	-73.06%	9.21%	331.86%	1017.53%
Accounts Receivable	137,003	136,590	140,526	108,264	207,601	380,535
Other Receivables	-	25,216	5,483	879.37	8,342	25,375
Receivables	137,003	163,079	147,156	109,917	216,427	405,987
Inventory	239,360	232,170	195,621	254,663	353,248	366,364
Prepaid Expenses	-	48,139	41,430	37,918	43,946	42,383
Other Current Assets	77,066	27,257	23,045	44,796	97,668	35,614
Total Current Assets	885,678	938,393	964,970	2,517,266	2,606,788	1,289,261
Property, Plant & Equipment	487,475	485,610	551,500	468,635	207,128	115,250
Long-Term Investments	285,751	239,993	212,176	62,563	56,133	8,151
Goodwill	1,368,028	1,371,292	1,211,637	44,004	35,320	4,867
Other Intangible Assets	704,187	723,116	728,677	23,366	2,724	650.57
Long-Term Accounts Receivable	-	216.56	742.81	316.96	-0	-
Long-Term Deferred Tax Assets	16,371	16,912	14,683	38,175	18,030	21,559
Other Long-Term Assets	97,354	111,175	102,303	105,842	106,999	21,039
Total Assets	3,844,843	3,888,464	3,788,831	3,261,922	3,033,933	1,461,651
Accounts Payable	38,508	49,274	31,875	45,251	134,631	429,329
Accrued Expenses	-	12,702	12,373	10,609	6,468	24,169
Short-Term Debt	4,345	4,345	4,973	6,358	170,700	1,694
Current Portion of Long-Term Debt	34.83	44.55	128,940	-	-	-
Current Portion of Leases	7,011	7,049	7,030	12,607	6,590	4,267
Current Income Taxes Payable	7,634	5,212	6,336	190,121	351,979	112,251
Other Current Liabilities	121,524	97,937	129,231	32,034	109,502	117,693
Total Current Liabilities	179,058	176,564	320,758	296,980	779,869	689,402
Long-Term Debt	606,518	586,300	461,831	147.43	274.92	-
Long-Term Leases	12,834	13,124	5,702	11,581	18,103	14,536
Long-Term Deferred Tax Liabilities	120,124	127,155	147,194	4.64	-	-
Other Long-Term Liabilities	43,361	49,035	18,319	5,661	3,165	7.92
Total Liabilities	966,072	956,184	957,285	315,141	801,724	704,100
Common Stock	60,875	62,239	62,239	52,192	51,636	46,659
Additional Paid-In Capital	713,217	913,100	913,099	616,185	579,565	77,070
Retained Earnings	1,944,328	1,786,982	1,885,440	2,382,819	1,668,702	625,083
Treasury Stock	-	-118,117	-99,691	-99,691	-99,644	-
Comprehensive Income & Other	152,931	279,129	62,573	-7,202	19,092	-791.43
Total Common Equity	2,871,351	2,923,334	2,823,660	2,944,301	2,219,351	748,021
Minority Interest	7,420	8,947	7,887	2,480	12,858	9,530
Shareholders' Equity	2,878,771	2,932,281	2,831,546	2,946,781	2,232,209	757,551
Total Liabilities & Equity	3,844,843	3,888,464	3,788,831	3,261,922	3,033,933	1,461,651
Total Debt	630,743	610,862	608,476	30,694	195,668	20,498
Net Cash (Debt)	-198,495	-143,112	-50,759	2,039,277	1,699,830	418,416
Net Cash Growth	-	-	-	19.97%	306.25%	1594.22%
Net Cash Per Share	-1633.71	-1171.11	-457.86	20131.28	17430.38	4474.28
Filing Date Shares Outstanding	119.62	120.62	122.35	102.25	101.14	93.32
Total Common Shares Outstanding	119.62	120.62	122.35	102.25	101.14	93.32
Working Capital	706,621	761,830	644,212	2,220,286	1,826,919	599,859
Book Value Per Share	24004.10	24236.47	23079.02	28794.15	21943.04	8015.85
Tangible Book Value	799,137	828,926	883,346	2,876,932	2,181,307	742,503
Tangible Book Value Per Share	6680.67	6872.37	7219.97	28135.30	21566.89	7956.72
Land	87,395	87,538	88,988	83,771	40,358	8,759
Buildings	74,131	92,958	132,470	58,144	36,449	29,790
Machinery	132,767	252,710	294,004	212,481	95,420	52,067
Construction In Progress	168,056	160,947	114,144	139,232	38,237	29,318

Source: S&P Global Market Intelligence. Standard template. Financial Sources.